Article: Encore Medical Corporation Enters Agreement to Sell U.S. Consumer Product Line.

AUSTIN, Texas, June 9 /PRNewswire-FirstCall/ -- Encore Medical Corporation announced today that it has entered into an agreement to sell its Slendertone(R) U.S. consumer product line for cash consideration of approximately $6.8 million primarily for the Slendertone inventory and all of Encore's distribution rights to Slendertone products in the U.S. The purchaser is Bio-Medical Research Limited, an Ireland based private company, that developed, manufactures, distributes and owns all intellectual property rights to the Slendertone product line. Encore intends to use the net proceeds from this sale toward Encore's core Surgical Implant and Orthopedic Rehabilitation ...






Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!